Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2012-08-01Clinical Trial Update: Questionnaire and Fall Risk Assessment
A completed clinical trial update from MD Anderson Cancer Center describing questionnaire data collection and fall risk assessment in a pros…
-
CLINICAL_TRIALS trial_result · 2012-07-31Clinical Trial Update: Clinical Study of SU011248 in Subjects With High Risk Prostate Cancer Who Have Elected to Undergo Radical Prostatectomy [Phase 1]
Phase 1 clinical trial of SU011248 in high-risk prostate cancer patients undergoing radical prostatectomy has completed enrollment/status.
-
CLINICAL_TRIALS trial_result · 2012-07-31Clinical Trial Update: Urodynamic Evaluation in Post-radiation Salvage Prostatectomy Patients
A terminated clinical trial evaluating urodynamic function in men undergoing post-radiation salvage prostatectomy for prostate cancer.
-
CLINICAL_TRIALS trial_result · 2012-07-30Clinical Trial Update: Combination Chemotherapy With Ketoconazole in Treating Patients With Prostate Cancer [Phase 2]
A Phase 2 clinical trial evaluating the combination of chemotherapy with ketoconazole for prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2012-07-30Clinical Trial Update: Nerve-Sparing Radical Prostatectomy With or Without Nerve Grafting Followed by Standard Therapy for Erectile Dysfunction in Treating Patients With Localized Prostate Cancer [Phase 2]
A Phase 2 trial evaluating nerve-sparing radical prostatectomy with or without nerve grafting, followed by standard erectile dysfunction the…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-07-30Clinical Trial Update: Multicentric Study Comparing Carcinological and Functional Results of Surgery [Phase 3]
A Phase 3 multicenter trial evaluating surgical outcomes for prostate cancer, focusing on carcinological and functional results.
-
CLINICAL_TRIALS withdrawal · 2012-07-30Clinical Trial Update: Preoperative Docetaxel for Localized Progressive Castration-resistant Prostate Cancer (CRPC) [Phase 2]
A Phase 2 study evaluating preoperative docetaxel for localized progressive castration-resistant prostate cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-07-30Clinical Trial Update: Quality of Life in Men With High Risk Localized Prostate Cancer
This clinical trial evaluating quality of life in men with high-risk localized prostate cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2012-07-24Clinical Trial Update: MEN-10755 in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone Therapy [Phase 2]
Phase 2 clinical trial update for MEN-10755 in progressive prostate cancer that progressed after hormone therapy has completed.
-
CLINICAL_TRIALS research · 2012-07-24Clinical Trial Update: Tesetaxel in Chemotherapy-naive Patients With Progressive, Castration-resistant Prostate Cancer [Phase 2]
This is a Phase 2 clinical trial update for tesetaxel in chemotherapy-naive patients with progressive, castration-resistant prostate cancer.
-
FDA approval · 2012-07-20FDA Approved: BICALUTAMIDE — Supplemental Application (Accord Healthcare Inc.)
FDA approved a supplemental application for Accord Healthcare's generic bicalutamide.
-
FDA label_change · 2012-07-19FDA Approved: BICALUTAMIDE — Supplemental Application (Viona Pharmaceuticals Inc.)
The FDA granted a supplemental approval for bicalutamide from Viona Pharmaceuticals, indicating an update to the approved product (labeling/…
-
CLINICAL_TRIALS trial_result · 2012-07-19Clinical Trial Update: Genistein in Treating Patients With Localized Prostate Cancer Who Are Planning to Undergo Radical Prostatectomy [Phase 2]
A Phase 2 trial evaluating genistein for localized prostate cancer in patients planning radical prostatectomy has been terminated.
-
CLINICAL_TRIALS trial_result · 2012-07-18Clinical Trial Update: Efficacy and Safety of Zactima™ in Patients With Castration-refractory Metastatic Prostate Cancer [Phase 2]
This update reports the efficacy and safety results from a Phase 2 trial of Zactima (vandetanib) in patients with castration-refractory meta…
-
CLINICAL_TRIALS trial_result · 2012-07-16Clinical Trial Update: Lycopene in Treating Patients Undergoing Radical Prostatectomy for Prostate Cancer [Phase 2]
Phase 2 trial investigating lycopene for patients undergoing radical prostatectomy for prostate cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2012-07-12Clinical Trial Update: Lenalidomide and GM-CSF in Treating Patients With Prostate Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluated lenalidomide in combination with GM-CSF for patients with prostate cancer; results were posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-07-11Clinical Trial Update: Radiation Therapy With or Without Goserelin and Cyproterone in Treating Patients With Prostate Cancer [Phase 3]
This is an update on a Phase 3 clinical trial assessing radiation therapy with or without goserelin and cyproterone in patients with prostat…
-
CLINICAL_TRIALS trial_result · 2012-07-09Clinical Trial Update: Taxotere Prostate Cancer New Indication Registration Trial in China [Phase 3]
Phase 3 registration trial of Taxotere (docetaxel) for prostate cancer in China has completed.
-
FDA label_change · 2012-07-03FDA Approved: ZYTIGA — Supplemental Application (Janssen Biotech, Inc.)
The FDA approved a supplemental application for ZYTIGA (abiraterone acetate) submitted by Janssen Biotech, Inc.
-
CLINICAL_TRIALS trial_result · 2012-07-02Clinical Trial Update: Hormone Therapy in Treating Patients With Advanced Prostate Cancer [Phase 3]
A Phase 3 trial evaluating hormone therapy for advanced prostate cancer has completed; the snippet does not include efficacy or safety resul…
-
CLINICAL_TRIALS research · 2012-06-28Clinical Trial Update: Efficacy Study of Switching to a Lutenizing Hormone-releasing Hormone (LHRH) Antagonist From a LHRH Agonist to Treat Progressive Castrate Resistant Prostate Cancer (CRPC) [Phase 2]
Phase 2 clinical trial update evaluating switching from an LHRH agonist to an LHRH antagonist for progressive castration-resistant prostate …
-
CLINICAL_TRIALS trial_result · 2012-06-27Clinical Trial Update: ABT-751 in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy [Phase 1, Phase 2]
Phase 1/2 study of ABT-751 (E7070) in metastatic prostate cancer that progressed after hormone therapy; the trial was terminated with result…
-
CLINICAL_TRIALS trial_result · 2012-06-26Clinical Trial Update: Enbrel Versus Placebo With Radiation Therapy to Combat Fatigue and Cachexia [Phase 2, Phase 3]
A Phase 2/3 trial evaluating Enbrel (etanercept) plus radiation therapy versus placebo with radiation therapy to address fatigue and cachexi…
-
FDA approval · 2012-06-21FDA Approved: BICALUTAMIDE — Supplemental Application (Viona Pharmaceuticals Inc.)
The FDA approved a supplemental application for Bicalutamide by Viona Pharmaceuticals Inc.
-
CLINICAL_TRIALS trial_result · 2012-06-20Clinical Trial Update: Clinical Value of FEC-PET Combined With Endorectal MRI for Pre-therapeutic Staging of Prostate Cancer [Phase 3]
A Phase 3 trial evaluating FEC-PET combined with endorectal MRI for pre-therapeutic staging of prostate cancer has completed and posted its …